Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
This new facility significantly increases the company’s footprint for secondary packaging, storage, logistics, and distribution of clinical supplies to investigator sites across Europe. Featuring highly automated technology in a fully scalable, mixed-use space, the site will serve as a strategic logistics hub for shipping by road or air and its central location will help expedite clinical trial therapies to patients.
Download the site capabilities fact sheet for more information.